Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Flagrante Delictu who wrote (17126)	3/10/1998 10:09:00 PM
From: RXGOLF	Read Replies (2) of 32384

<<The problem I see with Evista in Canada is that the current sales force targets cancer specialists. They would have to learn about women's health issues & get to know a whole new kind of specialists in women's health>> Bernie, I am glad to hear that Ligand has a current sales force. IMO it isn't a big worry about their current targets. My experience is that the drug reps love new products to push to new physicians. They get tired of telling the same thing to the same people. Sure, they may have to learn the quirks of new office staff at the new practice locals, but most will enjoy the challenge! The happiest Reps I see, are the ones with a new and exciting product! Good Luck, RXGOLF

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next